IBO (Impact BioMedical) FCF Margin %: 15,666.67% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IBO Impact BioMedical Inc IBO
10 GF Score
Price $0.44
! 6 Warning Signs
View Full Analysis

What is Impact BioMedical FCF Margin %?

Impact BioMedical IBO -1.57% 10 FCF Margin % is 15,666.67% as of Jun. 2026. GuruFocus rates IBO with a GF Score™ of 10/100. The stock has 6 warning signs investors should review. Among 955 Biotechnology companies, Impact BioMedical ranks worse than 82.72% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Impact BioMedical's Free Cash Flow for the three months ended in Jun. 2026 was $0.47 Mil. Impact BioMedical's Revenue for the three months ended in Jun. 2026 was $0.00 Mil. Therefore, Impact BioMedical's FCF Margin % for the quarter that ended in Jun. 2026 was 15,666.67%.

As of today, Impact BioMedical's current FCF Yield % is -1.07%.

The historical rank and industry rank for Impact BioMedical's FCF Margin % or its related term are showing as below:

IBO' s FCF Margin % Range Over the Past 10 Years
Min: -5906.25   Med: -5036   Max: -1451.43
Current: -1451.43

During the past 7 years, the highest FCF Margin % of Impact BioMedical was -1451.43%. The lowest was -5906.25%. And the median was -5036.00%.

IBO's FCF Margin % is ranked worse than
82.72% of 955 companies
in the Biotechnology industry
Industry Median: -78.14 vs IBO: -1451.43

Impact BioMedical FCF Margin % Related Terms

Impact BioMedical FCF Margin % Historical Data

* Premium members only.

The historical data trend for Impact BioMedical's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Impact BioMedical FCF Margin % Chart

Impact BioMedical Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial -5,036.00 -5,036.00 0.00 0.00 -5,906.25

Impact BioMedical Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9,914.29 -3,405.56 1,414.29 -6,628.57 15,666.67

IBO vs ATYR, MCRB, TIL: FCF Margin % Comparison

For the Biotechnology subindustry, Impact BioMedical's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Impact BioMedical FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Impact BioMedical's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Impact BioMedical's FCF Margin % falls into.


IBO
10GF Score
Impact BioMedical Inc IBO
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Impact BioMedical FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Impact BioMedical's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-1.89/0.032
=-5,906.25 %

Impact BioMedical's FCF Margin for the quarter that ended in Jun. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Jun. 2026 )/Revenue (Q: Jun. 2026 )
=0.47/0.003
=15,666.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 15,666.67% mean?
Impact BioMedical (IBO) has a FCF Margin % of 15,666.67% as of Jun. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Impact BioMedical and its competitors. According to the industry distribution chart, Impact BioMedical ranks #790 out of 955 companies in the Biotechnology industry, placing it in the top 82.7%.
Is Impact BioMedical's FCF Margin % too high?
Impact BioMedical's current FCF Margin % is 15,666.67%. Based on the distribution chart, Impact BioMedical ranks #790 out of 955 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Impact BioMedical has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Impact BioMedical's FCF Margin % compare to ATYR and MCRB?
According to the Biotechnology industry distribution chart, Impact BioMedical ranks #790 out of 955 companies for FCF Margin %. This places Impact BioMedical in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Impact BioMedical and its competitors. Impact BioMedical's current FCF Margin % is 15,666.67%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Impact BioMedical stock overvalued right now?
Impact BioMedical (IBO) has a current FCF Margin % of 15,666.67%. The current FCF Margin % is 15,666.67%. Impact BioMedical's overall GF Score™ is 10/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Impact BioMedical (IBO), the current FCF Margin % is 15,666.67% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Impact BioMedical Business Description

Address 1400 Broadfield Boulevard, Suite 130, Houston, TX, USA, 77084
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.
10GF Score

Get the complete analysis for IBO

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.44
Price